Volume 15, Number 11—November 2009
Research
Epidemic of Plasmodium falciparum Malaria Involving Substandard Antimalarial Drugs, Pakistan, 2003
Toby Leslie
, Harpakash Kaur, Nasir Mohammed, Kate Kolaczinski, Rosalynn L. Ord, and Mark Rowland
, Harpakash Kaur, Nasir Mohammed, Kate Kolaczinski, Rosalynn L. Ord, and Mark RowlandTable 3
Frequency of treatment failure for infection with Plasmodium falciparum or P. vivax, by group, sex, and age, Pakistan, October 2003*
| Characteristic | Failure rate (%) | Crude OR (95% CI) | Adjusted OR (95% CI) |
|---|---|---|---|
| Group | |||
| Comparison group | 4/40 (10.0) | 1 | 1 |
| Ashgaroo |
43/151 (28.5) |
3.6 (1.2–10.7) |
3.2 (1.0–10.1) |
| Sex | |||
| M | 27/90 (30.0) | 1 | 1 |
| F |
20/99 (20.2)† |
0.6 (0.3–1.2) |
0.5 (0.3–1.2) |
| Age group, y | |||
| 0–5 | 16/40 (40.0) | 1 | 1 |
| 6–10 | 21/72 (29.2) | 0.6 (0.3–1.4) | 0.6 (0.3–1.1) |
| 11–20 | 4/33 (12.2) | 0.2 (0.1–0.7) | 0.3 (0.1–1.0) |
| >20 | 6/46 (13.0) | 0.2 (0.1–0.6) | 0.3 (0.1–0.8) |
*OR, odds ratio; CI, confidence interval.
†Results exclude losses to follow-up.
